JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

Codexis Inc

Closed

SectorHealthcare

2.42 -6.56

Overview

Share price change

24h

Current

Min

2.39

Max

2.59

Key metrics

By Trading Economics

Income

7.4M

-13M

Sales

7.8M

15M

EPS

-0.16

Profit margin

-86.587

Employees

188

EBITDA

7.6M

-13M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+143.46% upside

Dividends

By Dow Jones

Next Earnings

6 lis 2025

Market Stats

By TradingEconomics

Market Cap

11M

243M

Previous open

8.98

Previous close

2.42

News Sentiment

By Acuity

50%

50%

176 / 373 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Codexis Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 paź 2025, 23:28 UTC

Hot Stocks

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

29 paź 2025, 23:07 UTC

Earnings

Prudential PLC 3Q New Business Profit Up 13%

30 paź 2025, 00:00 UTC

Earnings

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

30 paź 2025, 00:00 UTC

Earnings

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

30 paź 2025, 00:00 UTC

Earnings

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

29 paź 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

29 paź 2025, 23:40 UTC

Earnings

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

29 paź 2025, 23:38 UTC

Market Talk

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

29 paź 2025, 23:25 UTC

Earnings

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

29 paź 2025, 22:51 UTC

Earnings

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

29 paź 2025, 22:45 UTC

Earnings

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

29 paź 2025, 22:41 UTC

Earnings

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

29 paź 2025, 22:41 UTC

Earnings

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

29 paź 2025, 22:09 UTC

Earnings

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

29 paź 2025, 22:08 UTC

Market Talk
Earnings

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

29 paź 2025, 21:58 UTC

Earnings

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

29 paź 2025, 21:58 UTC

Earnings

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

29 paź 2025, 21:57 UTC

Earnings

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

29 paź 2025, 21:54 UTC

Earnings

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

29 paź 2025, 21:46 UTC

Earnings

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

29 paź 2025, 21:43 UTC

Earnings

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

29 paź 2025, 21:43 UTC

Earnings

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

29 paź 2025, 21:42 UTC

Earnings

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

29 paź 2025, 21:42 UTC

Earnings

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

29 paź 2025, 21:41 UTC

Earnings

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

29 paź 2025, 21:41 UTC

Earnings

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

29 paź 2025, 21:41 UTC

Earnings

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

29 paź 2025, 21:41 UTC

Earnings

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

29 paź 2025, 21:40 UTC

Earnings

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

29 paź 2025, 21:39 UTC

Earnings

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Peer Comparison

Price change

Codexis Inc Forecast

Price Target

By TipRanks

143.46% upside

12 Months Forecast

Average 6.33 USD  143.46%

High 11 USD

Low 3 USD

Based on 5 Wall Street analysts offering 12 month price targets forCodexis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

3

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

2.25 / 2.53Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

176 / 373 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
help-icon Live chat